English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
Multiple myeloma highlights from EHA 2016
Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip...
Multiple myeloma highlights from EHA 2016 ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy )
10 Jun 2016
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
Dr Charles De Bock - KU Leuven, Leuven, Belgium
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )
10 Jun 2016
RNA regulation of JAK-STAT pathways in CML
Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA
RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )
10 Jun 2016
An overview of MCL from EHA 2016
Professor Simon Rule and Professor Steven Le Gouill
An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )
10 Jun 2016
Ten years of letrozole improves survival and quality of life in early-diagnosed...
Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
6 Jun 2016
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
Update on olaparib in ovarian cancer
Prof Jonathan Ledermann - University College Hospital Medical School, London, UK
Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )
6 Jun 2016
Phase I study of sapacitabine and seliciclib in patients with advanced solid...
Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours ( Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA )
6 Jun 2016
ASCO 2016: Plenary Session Review
Dr Julie Vose - President of ASCO
ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )
5 Jun 2016
Chemotherapy combination with capecitabine extends survival after pancreatic...
Prof John Neoptolemos - University of Liverpool, Liverpool, UK
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )
5 Jun 2016
Novel antibody helps patients with advanced gastric cancer live longer
Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Novel antibody helps patients with advanced gastric cancer live longer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
5 Jun 2016
Double stem-cell transplant improves outcomes for children with high-risk...
Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
5 Jun 2016
<1...4748495051...76>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top